CBD suppresses GBM invasion by organotypic brainslice and decreases Id-1 expression and GBM progression in vivo. Similarly, CBD increased ROS levels in GSCs,reducing cell survival, phosphorylated (p)-AKT, self-renewal, andenhancing survival in GSC-bearing mice. This evidence concerns the gene AKT1 and glioblastoma.